Mithramycin A

CAS: 18378-89-7

Ref. TR-M369500

Informação sobre produto

• Nome: Mithramycin A
• Sinónimos: Mithramycin, A 2371, Antibiotic LA 7017, Aureolic Acid, Mithracin, Mitramycin, NSC 24559, PA 144, Plicamycin, Plicatomycin,[1S(2S,3S)]-5-Deoxy-1-C-[7-[[2,6-dideoxy-3-O-(2,6-dideoxy-β-D-arabino-hexopyranosyl)-β-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-β-D-ribo-hexopyranosyl-(1→3)-O-2,6-dideoxy-β-D-arabino-hexopyranosyl-(1→3)-2,6-dideoxy-β-D-lyxo-hexopyranosyl)oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-1-O-methyl-D-threo-2-pentulose
• Marca: TRC
• Descrição: Applications Mithramycin A is an anticancer antibiotic that selectively binds to G-C-rich DNA in the presence of Mg2+ or Zn2+, inhibiting RNA and DNA polymerase action. Mithramycin A inhibits c-myc expression and induces myeloid differentiation of HL-60 promyelocytic leukemia cells.References Miller, et al.: Am. J. Med. Sci., 294, 388 (1987), Demicheli, et al.: Biochem. Biophys. Res. Commun., 177 511 (1991), Max, H., et al.: Cancer Res., 63, 7436 (2003), Lockman, J., et al.: J. Med. Chem., 53, 8734 (2010),

Propriedades químicas

• Peso molecular: 1085.15
• Fórmula: C₅₂H₇₆O₂₄
• Cor/forma: Yellow Crystalline Powder
• InChI: InChI=1S/C52H76O24/c1-18-29(72-34-14-30(43(58)21(4)68-34)73-33-13-28(54)42(57)20(3)67-33)12-26-10-25-11-27(49(66-9)48(63)41(56)19(2)53)50(47(62)39(25)46(61)38(26)40(18)55)76-36-16-31(44(59)23(6)70-36)74-35-15-32(45(60)22(5)69-35)75-37-17-52(8,65)51(64)24(7)71-37/h10,12,19-24,27-28,30-37,41-45,49-51,53-61,64-65H,11,13-17H2,1-9H3/t19-,20-,21-,22-,23-,24-,27+,28-,30-,31-,32-,33+,34+,35+,36+,37+,41+,42-,43-,44-,45+,49+,50+,51-,52+/m1/s1
• Chave InChI: InChIKey=RSLJLPFHYCLDBE-AYVREFAGSA-N
• SMILES: CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@@H]1C[C@H](O[C@@H]2C[C@H](O[C@@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H](O)[C@H](C)O2)[C@@H](O)[C@H](C)O1